OPOzge Tugce Pasaoglu

Ozge Tugce Pasaoglu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ozge Tugce Pasaoglu has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of Ketorolac on Colorectal Anastomosis in Rats

    by Salim İlksen Başçeken, Nazmi Onur Okudur, Utku Tantoğlu, Şeref Dokcu, Deniz Tikici, Nurian Ohri, Caner Baysan, Özge Tuğçe Paşaoğlu, Hatice Paşaoğlu, İbRahim Ethem Geçim

    Despite being a significant cause of morbidity and mortality, colorectal anastomoses are an indisputable gastrointestinal system reconstruction surgery routine. Many patient- and disease-specific factors, including surgical technique, affect anastomotic healing. This study discusses the effects of ketorolac, used for analgesia after colorectal surgery, on the continuity of colorectal anastomoses and intraabdominal adhesions in a rat model. A prospective randomized study was performed at Laboratory of Experimental Animals and Research in the Institute. Thirty Wistar Albino rats were randomized into three equal groups, each consisting of 10 rats. Following rectal transection, end-to-end colorectal anastomosis was performed. During the postoperative period, animals received intramuscular injections of 10 mg/kg isotonic saline, 20 mg/kg meperidine, and 1 mg/kg ketorolac. On the post- operative day seven, the anastomotic segment was resected, and the Nair Score, anastomotic burst pressure, and OH-Proline levels were compared. The OH-Proline values were not statistically significant between the groups (P = 0.566). There was no statistically significant difference between the groups in terms of Nair Scores (P = 0.118). The anastomotic burst pressures of the groups were statistically significantly different (P = 0.017). The anastomotic burst pressures in the group receiving ketorolac were statistically significantly higher than the group receiving meperidine (P = 0.020). In conclusion, this study did not associate perioperative use of ketorolac with anastomotic leakage in the rat model.

  • Protective Effects of N-Acetylcysteine, Carvedilol, and Paricalcitol in a Rat Model of Peritoneal Fibrosis

    by Kursad Onec, Özgür Ekinci, Özge Paşaoğlu, Kadriye Altok

    Aim: This study aimed to evaluate the potential protective effects of paricalcitol, N-acetylcysteine (NAC), and carvedilol in a rat model of chlorhexidine gluconate–induced peritoneal fibrosis.Material and Methods: Thirty-six female Wistar albino rats were randomized into six groups (n=6 each). Peritoneal fibrosis was induced with daily intraperitoneal chlorhexidine gluconate injections for 21 days. Treatment groups received paricalcitol, NAC, or carvedilol, alone or in combination. Serum TGF-β1 levels and histopathological parameters (peritoneal thickness, fibrosis, inflammation, vascularization) were assessed.Results: Serum TGF-β1 was significantly higher in the chlorhexidine group compared to controls (58.29 ± 4.40 vs. 49.06 ± 2.35 ng/mL, p<0.05). NAC significantly reduced TGF-β1 compared to chlorhexidine alone (46.76 ± 4.79 ng/mL, p<0.05). Peritoneal thickness was markedly increased in the chlorhexidine group (245 ± 27.3 µm vs. 22.3 ± 2.6 µm in controls, p<0.01) but attenuated by NAC (169.8 ± 30.8 µm, p<0.01) and carvedilol (146.5 ± 43.1 µm, p<0.01). Fibrosis and inflammation scores were also reduced in NAC and carvedilol groups (all p<0.05). Paricalcitol alone showed only partial and non-significant effects.Conclusions: NAC demonstrated consistent antifibrotic and anti-inflammatory effects, while carvedilol provided moderate benefit and paricalcitol had limited efficacy. These findings suggest that antioxidant therapy, particularly NAC, may represent a potential strategy for preserving peritoneal membrane integrity, though further studies are warranted.

  • Open Access

    Elevated Cadmium Levels in Dialysis Patients and Their Links to Inflammation, Oxidative Stress, and Malnutrition

    by Kursad Onec, Yasemin Erten, Özge Paşaoğlu, Fatma Ayerden Ebinç, Gülay Ulusal Okyay, Salih İnAl, Hatice Paşaoğlu, Serpil Müge Değer

    Aim: This study aimed to compare blood cadmium (Cd) levels between hemodialysis (HD) and peritoneal dialysis (PD) patients and healthy controls, and to evaluate the associations between Cd levels and inflammatory, oxidative, and nutritional markers. Material and Methods: Sixty-one dialysis patients (31 HD, 30 PD) and 15 healthy controls were included in this cross-sectional study. Whole-blood Cd was measured by atomic absorption spectrometry and corrected for hemoglobin (cCd). Serum interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), malondialdehyde (MDA), and advanced oxidation protein products (AOPP) were analyzed as indicators of inflammation and oxidative stress. Results: Both whole-blood Cd and cCd levels were significantly higher in both HD and PD patients compared with healthy controls (p=0.021 and p=0.001, respectively), while no statistically significant difference was observed between the two dialysis modalities. Correlation analyses demonstrated that Cd levels were positively correlated with inflammatory and oxidative stress markers, including IL-6 (rs=0.338, p=0.003), hs-CRP (rs=0.464, p=0.001), MDA (rs=0.464, p=0.001), and AOPP (rs=0.454, p<0.001). In contrast, cCd levels showed a significant negative correlation with serum albumin concentrations (rs=-0.454, p=0.001). Conclusion: Cd accumulation is markedly increased in dialysis patients regardless of treatment modality and is closely linked to systemic inflammation, oxidative damage, and reduced nutritional status. Environmental Cd exposure may represent an under-recognized contributor to adverse clinical outcomes in chronic kidney disease (CKD), and preventive strategies to minimize Cd burden may help improve prognosis in this population.

  • Open Access

    The Relationship of Gallestone Disease with Serum RBP4 Level, Vitamın D, Lipid Profile, Insulin Resistance and Uric Acid Levels

    by Bediz Kurt İnCi, Kamil İnCi, Özge Paşaoğlu, Hatice Pasaoglu, Gıyasettin Şükrü Dumlu

    Objective: The metabolic parameters associated with gallstones are the subject of numerous studies. RBP4, an adipokine, has been linked to various metabolic diseases; however, no study in the literature establishes its relationship with gallstone disease. Therefore, our study aimed to evaluate the biochemical parameters associated with gallstone disease, primarily serum RBP4. Material and Method: Between 2015 and 2016, abdominal ultrasound, serum biochemical tests, lipid profiles, uric acid, insulin, and fasting glucose values were available for 80 patients who presented to our hospital’s gastroenterology clinic, were included in the study. RBP4 levels were analyzed in the serum samples obtained from the patients. Results: Out of the 80 participants in the study, 42 had gallstones, while 38 did not. Among the biochemical parameters, no significant difference was found between the groups in terms of total cholesterol values (p= 0.483), LDL values (p=0.224), and TG values (p=0.764). A significant difference was observed between the two groups regarding HDL values(p=0.017). No significant difference was found between the two groups in terms of serum uric acid (p=0.411), fasting glucose (p=0.214), fasting insulin, HOMA-IR score (p=0.157), and vitamin D levels (p=0.340). The mean±SD values of the studied serum RBP-4 levels in the participants were determined as 40.24±7.12 in the control group and 39.75±8.55 in the patient group. No statistically significant difference was found between the two groups (p=0.776). In correlation analyses, a significant positive correlation was found between RBP4 and vitamin D levels (r: 0.277, p= 0.013), total cholesterol (r: 0.268, p=0.016), triglycerides (r: 0.387, p


  • Effects of Acute Malathion Exposure on Renal Oxidant and Antioxidant Balance in Rats

    by Ozge Tugce Pasaoglu, Bayram Sen, Murat Ekremoglu, Cinar Severcan, Hatice Pasaoglu

    Objective: Pesticides have been used in agriculture to enhance food production by eradicating undesired insects and controlling disease vectors. Malathion is one of the most widely used organophosphate pesticides. However, it has been postulated that organophosphate pesticides lead to oxidative stress through formation of excessive reactive oxygen species and disrupting the antioxidant defense systems. Methods: Four groups (n=6) were designed to evaluate the effects of different doses of acute malathion exposure on rat kidney. Control group was given only corn oil. Malathion dissolved in corn oil was administered to Group 2 (100 mg/kg), Group 3 (200 mg/kg) and Group 4 (400 mg/kg) via oral gavage. The rats were sacrificed after 24 hours and renal tissue supernatants are analyzed to determine cholinesterase (ChE) activity, total oxidant status (TOS), TNF-α, advanced glycation end products (AGEs), advanced oxidation protein products (AOPP), superoxide dismutase (SOD) activity, malondialdehyde (MDA), and paraoxonase 1-arylesterase activity (PON1-ARE). Results: ChE activities decreased, TOS levels and TNF- α levels increased in all experimental groups compared with control group (p'<0.05). AGEs levels of the high dose group elevated significantly compared with control and group 3 (p'<0.05). SOD levels of group 3 and 4, and MDA levels of group 3 showed an increase compared with control group, however this did not reach statistical significance (p'=0.054). PON1-ARE levels diminished in group 3 and 4 compared with control (p'<0.05). AOPP levels did not change significantly (p'=0.735). Conclusion: Acute exposure to malathion disrupts the oxidant-antioxidant balance and causes oxidative stress in kidneys.


  • Positive Effects of Melatonin on Renal Nitric Oxide-Asymmetric Dimethylarginine Metabolism in Fructose-Fed Rats

    by Ozge Tugce Pasaoglu, Filiz Sezen Bircan, Turgut Topal, Nurten Turkozkan

    Background: The incidence of metabolic syndrome is increasing worldwide and this is mainly attributed to high carbohydrate intake, especially of fructose, and sedentary lifestyles. Nitric oxide (NO), which is synthesized by nitric oxide synthase (NOS) enzymes, is a crucial molecule for endothelial and renal health. Asymmetric dimethylarginine (ADMA) is the most potent inhibitor of NOS and it is degraded by dimethylarginine dimethylaminohydrolase (DDAH). The aim of this study was to investigate the effects of melatonin on renal NO-ADMA metabolism using a metabolic syndrome model achieved by fructose administration. Methods: Thirty-two rats were randomly divided into four groups (n = 8): (1) control group, (2) fructose group, (3) melatonin group, and (4) fructose + melatonin group. Fructose (20%) was given in drinking water. Melatonin [20 mg/(kg·day)] was administered in 0.1% ethanol solution. After 8 weeks, kidney tissues were collected to measure tissue levels of nitrite/nitrate (NOx), ADMA, arginine, symmetric dimethylarginine, DDAH activity, and endothelial NOS (eNOS) and inducible NOS (iNOS) protein levels. Results: Fructose led to low arginine/ADMA ratios (AARs) (P < 0.008). Tissue NOx levels of the fructose + melatonin group were significantly higher than those of the fructose group (P < 0.008). ADMA and arginine were significantly higher in the fructose + melatonin group than the control group (P < 0.008). The DDAH activity of the fructose and fructose + melatonin groups was significantly higher than that of the control group (P < 0.008). eNOS protein levels showed no difference and iNOS protein was not detected in any of the groups. Conclusions: A diminished AAR indicates the toxicity of fructose in the kidneys. Melatonin has beneficial effects on the NO-ADMA pathway as it restores NOx levels and increases DDAH activity, possibly as a result of a compensatory mechanism to metabolize increased ADMA.


  • Open Access

    FGF23, alpha-Klotho and vitamin D mediated calcium-phosphate metabolism in haemodialysis patients

    by Ozge Pasaoglu, Ayse Senelmis, Ozant Helvaci, Ulver Derici, Hatice Pasaoglu

    Background: Klotho is a protein that acts as a co-receptor for FGF23. FGF23-Klotho axis has great importance regarding to the regulation of mineral metabolism by kidneys. In this study, we analyzed FGF23, αKlotho, 1,25-dihydroxyvitamin D3, 25-hydroxyvitamin D, parathormone, calcium and phosphate levels of hemodialysis patients in order to investigate the nature of the mineral metabolism disruption in chronic kidney diseases. Methods: Sixty hemodialysis patients and 34 healthy controls were included in the study. Serum iFGF, cFGF, soluble αKlotho were analyzed using ELISA kits. 1,25-dihydroxyvitamin D3 was determined using LC-MS/MS. Calcium, phosphate, iPTH and 25-hydroxyvitamin D were measured using autoanalyzers. Results: In hemodialysis patients, iFGF23, cFGF23, iPTH and P levels were significantly higher and 1,25-dihydroxyvitamin D3, αKlotho and Ca levels were significantly lower compared with the control group. There was no significant difference in 25-hydroxyvitamin D levels. Conclusion: Our study showed that lack of sufficient amounts of αKlotho is crucial for mineral metabolism disruptions seen as a complication of chronic kidney diseases. Despite the high levels of the hormone, FGF23 is unable to accomplish its function properly, likely due to deteriorated kidney function in hemodialysis patients.


  • Role of silymarin (Silybum marianum) in the prevention of colistin-induced acute nephrotoxicity in rats

    by Burak Dumludag, Mehmet Kursat Derici, Osman Sutcuoglu, Betul Ogut, Ozge Tugce Pasaoglu, Ipek Isık Gonul, Ulver Derici

    Silymarin (Silybum marianum) has some protective effects against drug toxicity (cisplatin, acetaminophen, adriamycin, gentamicin etc.). Colistin is a strong antimicrobial, which is frequently used in the treatment of resistant gram-negative bacterial infections in recent years although it has nephrotoxic potential. This study was aimed to determine the role of silymarin against colistin-induced acute nephrotoxicity (CIN). Rats were randomly divided into four groups. The control group was treated with tap water whereas groups 2 and 3 received silymarin (orally, 100 mg/kg/day) and colistin (intraperitoneally, 750.000 IU/kg/day) for seven days, respectively. Group 4 received both 750,000 IU/kg/day colistin and 100 mg/kg/day silymarin for seven days. After euthanasia, histopathological and biochemical examinations were completed for the kidney tissue specimens and blood samples. All parameters of the control and silymarin groups were similar. Severe weight loss was seen in the groups receiving colistin (groups 3 and 4). Silymarin significantly increased glutathione peroxidase and superoxide dismutase levels when administered with colistin in group 4 only. Acute tubular injury, tubular necrosis, meduller congestion, interstitial inflammation and apoptotic indices of colistin group were significantly higher than the control group. The administration of colistin with silymarin (group 4) was able to make some improvements in tubular necrosis and significant increase in antioxidant capacity. Silymarin increased antioxidant enzyme activity only when used in combination with colistin. The effects of silymarin may become more pronounced when used at higher doses or with a longer duration of treatment and may prevent nephrotoxicity.


  • Open Access

    Relationship between plasma YKL-40 levels and endothelial dysfunction in chronic kidney disease

    by Gül Sema Yildiran Keski̇n, Özant Helvaci, Çağri Yayla, Özge Tuğçe Paşaoğlu, Çağlar Keski̇n, Seli̇m Turgay Arinsoy, Ülver Deri̇cİ

    Aims: We aimed to evaluate relationship between YKL-40 and endothelial dysfunction in chronic kidney disease. Patients/methods: Twenty-nine hemodialysis patients, 101 patients with non-dialytic (stage 2, 3, 4, 5ND) chronic kidney disease (CKD) and 38 healthy individuals as a control group were included. YKL-40 levels were measured with ELISA. Endothelial dysfunction was indirectly measured with Flow-mediated dilatation percentage (FMD) in the brachial artery. Results: YKL-40 levels were higher in CKD patients than controls and highest in HD patients (p=.001). Adversely FMD values were lower in non-dialytic CKD patients and lowest in HD patients (p=.001). YKL-40 negatively correlated with eGFR and FMD values (r=-0,674 and r=-0,471 respectively). Conclusion: This study shows that YKL-40 increases with CKD stage and is negatively correlated with FMD measurements.


  • The effects of caffeine on the renal antioxidant activity in rats / Ratlarda böbrek antioksidan aktivitesi üzerine kafeinin etkileri

    by Ebru Ofluoğlu Demir, Canan Yılmaz Demirtaş, Özge Tuğçe Paşaoğlu

    Objective: In our study, the short-term effects of caffeine on the renal antioxidant activity in rats were investigated. Methods: Caffeine was given orally at two different doses: 30 mg/kg and 100 mg/kg (a high non-toxic dose). The current study included 30 rats, which were divided into 3 groups: a control group and two caffeine-treated groups. Group 1 was given caffeine at 30 mg/kg and Group 2 was given caffeine at 100 mg/kg for 14 days. We measured advanced oxidation protein products (AOPP), malondialdehyde (MDA) and nitric oxide (NO) levels in the kidney tissue following caffeine administration. In addition, we also evaluated superoxide dismutase (SOD), and glutathione S transferase (GST) activities in the kidney tissue. Results: Our results showed that caffeine administration decreased lipid peroxidation and advanced oxidation protein products in kidney. Especially, MDA levels in the kidney tissue of the caffeine-treated groups decreased significantly as a result of the dose. NO levels in the kidney tissue of the caffeine-treated groups were higher than those in the control group. GST activities in the kidney tissue of rats in the caffeine groups also increased significantly. In our study, we did not observe significant changes in renal SOD activities upon caffeine consuption. Conclusion: These results show that short-term consumption of two different doses of caffeine may protect against oxidative stress in the kidney tissue of rats. This effect is related to the caffeine dosage. Determining the mechanisms and antioxidant effects of caffeine at suitable dose requires advanced animal and human studies.